News

Heron Therapeutics to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference

Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on developing novel best-in-class treatment solutions to address some of the biggest unmet patient needs, announced that Barry D. Quart, Pharm.D., Chief Executive Officer of Heron Therapeutics, will present at the Bank of America Merrill Lynch 2017 Healthcare Conference on Tuesday, May 16, 2017, at 2:20 p.m. PT (5:20 p.m. ET) at the Encore at Wynn Las Vegas.

2017-06-27T12:18:53+00:00